Skip to content

BD BBL™ Modified Thayer-Martin (MTM II) Agar 221568Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ Modified Thayer-Martin (MTM II) Agar, Ctn. of 100 plates · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10382902215681), received between Jun 8, 2023 and Jun 8, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Markings/Labelling Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Markings/Labelling Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 8, 2023Device Markings/Labelling Problem; Device Markings/Labelling Problem

    IT WAS REPORTED THAT NO LABEL INFORMATION WAS SEEN IN TEN BD BBL¿ MODIFIED THAYER-MARTIN (MTM II) AGAR. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: NO PRODUCT NAME, EXPIRATION DATE AND LOT NUMBER ON PLATE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17087357 ↗

Other CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA devices

All CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page